Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury

Journal of Clinical Investigation

Volumn 115, Issue 4, 2005, Pages 849-859

  Luedde, Tom ^a   Assmus, Ulrike ^a   Wüstefeld, Torsten ^a   Meyer Zu Vilsendorf, Andreas ^a   Roskams, Tania ^b   Schmidt Supprian, Mark ^c   Rajewsky, Klaus ^c   Brenner, David A ^d   Manns, Michael P ^a   Pasparakis, Manolis ^e   Trautwein, Christian ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c CENTER FOR BLOOD RESEARCH   (United States)

^d Columbia University ^*  (United States)

^e EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AS 602868; I KAPPA B KINASE INHIBITOR; I KAPPA B KINASE INHIBITOR 1; I KAPPA B KINASE INHIBITOR 2; I KAPPA B KINASE INHIBITOR 2 INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN ESSENTIAL MODULATOR; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; EMBRYO DEATH; GENE DELETION; HEMORRHAGIC SHOCK; HEPATITIS; KNOCKOUT MOUSE; LIVER CELL; LIVER ISCHEMIA; LIVER NECROSIS; LIVER PROTECTION; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY;

EID: 20144388823     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI23493     Document Type: Article

References (47)

1. Karin, M., and Lin, A. 2002. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3:221-227.
2. Pahl, H.L. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 18:6853-6866.
3. DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E., and Karin, M. 1997. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 388:548-554.
4. Karin, M. 1999. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene. 18:6867-6874.
5. Mercurio, F., et al. 1997. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science. 278:860-866.
6. Regnier, C.H., et al. 1997. Identification and characterization of an IkappaB kinase. Cell. 90:373-383.
7. Mercurio, F., et al. 1999. IkappaB kinase (IKK)-associated protein I, a common component of the heterogeneous IKK complex. Mol. Cell. Biol. 19:1526-1538.
8. Rothwarf, D.M., Zandi, E., Natoli, G., and Karin, M. 1998. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature. 395:297-300.
9. Yamaoka, S., et al. 1998. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 93:1231-1240.
10. Zandi, E., Chen, Y., and Karin, M. 1998. Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science. 281:1360-1363.
11. Delhase, M., Hayakawa, M., Chen, Y., and Karin, M. 1999. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science. 284:309-313.
12. Woronicz J.D., Gao, X., Cao, Z., Rothe, M., and Goeddel, D.V. 1997. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science. 278:866-869.
13. Zandi, E., Rothwarf, D.M., Delhase, M., Hayakawa, M., and Karin, M. 1997. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 91:243-252.
14. Hu, Y., et al. 1999. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science. 284:316-320.
15. Takeda, K., et al. 1999. Limb and skin abnormalities in mice lacking IKKalpha. Science. 284:313-316.
16. Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.F., and Verma, I.M. 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science. 284:321-325.
17. Li, Z.W., et al. 1999. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189:1839-1845.
18. Tanaka, M., et al. 1999. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity. 10:421-429.
19. Rudolph, D., et al. 2000. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14:854-862.
20. Luedde, T., Liedtke, C., Manns, M.P., and Trautwein, C. 2002. Losing balance: cytokine signaling and cell death in the context of hepatocyte injury and hepatic failure. Eur. Cytokine Netw. 13:377-383.
21. Fan, C., Li, Q., Ross, D., and Engelhardt, J.F. 2003. Tyrosine phosphorylation of 1 kappa B alpha activates NF kappa B through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation. J Biol. Chem. 278:2072-2080.
22. Zwacka, R.M., et al. 1998. Redox gene therapy for ischemia/reperfusion injury of ehe liver reduces API and NF-kappaB accivacion. Nat. Med. 4:698-704.
23. Zwacka, R.M., Zhang, Y., Zhou, W., Halldorson, J., and Engelhardt, J.F. 1998. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation. Hepatology. 28:1022-1030.
24. Pasparakis, M., et al. 2002. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature. 417:861-866.
25. Kellendonk, C., Opherk, C., Anlag, K., Schutz, G., and Tronche, F. 2000. Hepatocyte-specific expression of Cre recombinase. Genesis. 26:151-153.
26. Pasparakis, M., Schmidt-Supprian, M., and Rajewsky, K. 2002. IkappaB kinase signaling is essential for maintenance of mature B cells. J. Exp. Med. 196:743-752.
27. Kuhn, R., Schwenk, F., Aguet, M., and Rajewsky, K. 1995. Inducible gene targeting in mice. Science. 269:1427-1429.
28. Tiegs, G., Hentschel, J., and Wendel, A. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90:196-203.
29. Trautwein, C., et al. 1998. Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology. 114:1035-1045.
30. Maeda, S., et al. 2003. IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. Immunity. 19:725-737.
31. Schwabe, R.F., Bennett, B.L., Manning, A.M., and Brenner, D.A. 2001. Differential role of 1 kappa B kinase 1 and 2 in primary rat hepatocytes. Hepatology. 33:81-90.
32. Jaeschke, H. 2003. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am. J. Physiol. Gastrointest. Liver Physiol. 284:G15-G26.
33. Fan, C., et al. 2004. IkappaBalpha and IkappaB-beta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation. J. Clin. Invest. 113:746-755. doi.10.1172/JCI200417337
34. Rudiger, H.A., and Clavien, P.A. 2002. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology. 122:202-210.
35. Frelin, C., et al. 2003. AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-alpha in Jurkat leukemic cells. Oncogene. 22:8187-8194.
36. Sage, J., Miller, A.L., Perez-Mancera, P.A., Wysocki, J.M., and Jacks, T. 2003. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature. 424:223-228.
37. Jaeschke, H., Smith, C.V., and Mitchell, J.R. 1988. Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver. J. Clin. Invest. 81:1240-1246.
38. Jaeschke, H., and Farhood, A. 1991. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am. J. Physiol. 260:G355-G362.
39. Jaeschke, H. 1991. Reactive oxygen and ischemia/reperfusion injury of the liver. Chem. Biol. Interact. 79:115-136.
40. Fan, C., Yang, J., and Engelhardt, J.F. 2002. Temporal pattern of NFkappaB activation influences apoptotic cell fate in a stimuli-dependent fashion. J. Cell Sci. 115:4843-4853.
41. Chen, L.W., et al. 2003. The two faces of IKK and NFkappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9:575-581.
42. Arii, S., Teramoto, K., and Kawamura, T. 2003. Current progress in the understanding of and therapeutic strategies for ischemia and reperfusion injury of the liver. J. Hepatobiliary Pancreat. Surg. 10:189-194.
43. Wuestefeld, T., et al. 2003. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol. Chem. 278:11281-11288.
44. Knolle, P., et al. 1995. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J. Hepatol. 22:226-229.
45. Lüdde, T., et al. 2001. Ras adenoviruses modulate cyclin E protein expression and DNA synthesis after partial hepatectomy. Oncogens. 20:5264-5278.
46. Luedde, T., et al. 2003. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver. Hepatology. 37:833-841.
47. Luedde, T., et al. 2004. C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver. Hepatology. 40:356-365.